Monocyte chemoattractant protein-1 in spinal tuberculosis: -362G/C genetic variant and protein levels in Chinese patients

Diagnostic Microbiology and Infectious Disease

Volumn 78, Issue 1, 2014, Pages 49-52

  Guo, Chaofeng ^a   Zhang, Hongqi ^a   Gao, Qile ^a   He, Dan ^b   Tang, Mingxing ^a   Liu, Shaohua ^a   Deng, Ang ^a   Wang, Yuxiang ^a   Lu, Shijin ^a   Li, Jingsong ^a   Yin, Xinhua ^a   Guo, Qiang ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b First Hospital of Changsha   (China)

Author keywords

Gene polymorphism; Monocyte chemoattractant protein 1; Spinal tuberculosis

Indexed keywords

CYTOSINE; GUANINE; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; ALLELE; ARTICLE; CHINESE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOCYTE CHEMOTACTIC PROTEIN 1 BLOOD LEVEL; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; TUBERCULOUS SPONDYLITIS;

GENE POLYMORPHISM; MONOCYTE CHEMOATTRACTANT PROTEIN-1; SPINAL TUBERCULOSIS;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CHEMOKINE CCL2; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; PLASMA; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; SEQUENCE ANALYSIS, DNA; TUBERCULOSIS, SPINAL; YOUNG ADULT;

EID: 84890123946     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2013.07.024     Document Type: Article

References (26)

1. Algood H.M., Chan J., Flynn J.L. Chemokines and tuberculosis. Cytokine Growth Factor Rev 2003, 14:467-477.
2. Buijtels P.C., van de Sande W.W., Parkinson S., et al. Polymorphism in CC-chemokine ligand 2 associated with tuberculosis in Zambia. Int J Tuberc Lung Dis 2008, 12:1485-1488.
3. Charo I.F., Ransohoff R.M. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 2006, 354:610-621.
4. Deshmane S.L., Kremlev S., Amini S., et al. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res 2009, 29:313-326.
5. Feng W.X., Flores-Villanueva P.O., Mokrousov I., et al. CCL2-2518 (A/G) polymorphisms and tuberculosis susceptibility: a meta-analysis. Int J Tuberc Lung Dis 2012, 16:150-156.
6. Flores-Villanueva P.O., Ruiz-Morales J.A., Song C.H., et al. A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with increased susceptibility to pulmonary tuberculosis. J Exp Med 2005, 202:1649-1658.
7. Garq R.K., Somvanshi D.S. Spinal tuberculosis: a review. J Spinal Cord Med 2011, 34:440-445.
8. Hasan Z., Cliff J.M., Dockrell H.M., et al. CCL2 responses to Mycobacterium tuberculosis are associated with disease severity in tuberculosis. PLoS One 2009, 4:e8459.
9. Hussain R., Ansari A., Talat N., Hasan Z., Dawood G. CCL2/MCP-I genotype-phenotype relationship in latent tuberculosis infection. PLoS One 2011, 6:e25803.
10. Jamieson S.E., Miller E.N., Black G.F., et al. Evidence for a cluster of genes on chromosome 17q11-q21 controlling susceptibility to tuberculosis and leprosy in Brazilians. Genes Immun 2004, 5:46-57.
11. Kondratieva E., Logunova N., Majorov K., et al. Host genetics in granuloma formation: human-like lung pathology in mice with reciprocal genetic susceptibility to M. tuberculosis and M. avium. PLoS One 2010, 5:e10515.
12. Lee J.S., Song C.H., Lim J.H., et al. Monocyte chemotactic protein-1 production in patients with active pulmonary tuberculosis and tuberculous pleurisy. Inflamm Res 2003, 52:297-304.
13. Matsukawa A., Lukacs N.W., Standiford T.J., Chensue S.W., Kunkel S.L. Adenoviral-mediated overexpression of monocyte chemoattractant protein-1 differentially alters the development of Th1 and Th2 type responses in vivo. J Immunol 2000, 164:1699-1704.
14. Mendez A., Hernandez-Pando R., Contreras S., Aguilar D., Rook G.A. CCL2, CCL18 and sIL-4R in renal, meningeal and pulmonary TB; a 2 year study of patients and contacts. Tuberculosis (Edinb) 2011, 91:140-145.
15. Page S.H., Wright E.K., Gama L., Clements J.E. Regulation of CCL2 expression by an upstream TALE homeodomain protein-binding site that synergizes with the site created by the A-2578G SNP. PLoS One 2011, 6:e22052.
16. Peters W., Scott H.M., Chambers H.F., Flynn J.L., Charo I.F., Ernst J.D. Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis. Proc Natl Acad Sci USA 2001, 98:7958-7963.
17. Philips J.A., Ernst J.D. Tuberculosis pathogenesis and immunity. Annu Rev Pathol 2012, 7:353-384.
18. Raja A. Immunology of tuberculosis. Indian J Med Res 2004, 120:213-232.
19. Ramsay A., Steingart K.R., Cunningham J., Pai M. Translating tuberculosis research into global policies: the example of an international collaboration on diagnostics. Int J Tuberc Lung Dis 2011, 15:1283-1293.
20. Schirmer P., Renault C.A., Holodniy M. Is spinal tuberculosis contagious?. Int J Infect Dis 2010, 14:e659-e666.
21. Scott H.M., Flynn J.L. Mycobacterium tuberculosis in chemokine receptor 2-deficient mice: influence of dose on disease progression. Infect Immun 2002, 70:5946-5954.
22. Selvaraj P., Kurian S.M., Chandra G., Reetha A.M., Charles N., Narayanan P.R. Vitamin D receptor gene variants of BsmI, ApaI, TaqI, and FokI polymorphisms in spinal tuberculosis. Clin Genet 2004, 65:73-76.
23. Thye T., Nejentsev S., Intemann C.D., et al. MCP-1 promoter variant -362C associated with protection from pulmonary tuberculosis in Ghana West Africa. Hum Mol Genet 2009, 18:381-388.
24. Velez Edwards D.R., Tacconelli A., Wejse C., et al. MCP1 SNPs and pulmonary tuberculosis in cohorts from West Africa, the USA and Argentina: lack of association or epistasis with IL12B polymorphisms. Plos One 2012, 7:e32275.
25. World Health Organization (WHO) Global Tuberculosis Report 2012 2012.
26. Zhang H.Q., Deng A., Guo C.F., et al. Association between FokI polymorphism in vitamin D receptor gene and susceptibility to spinal tuberculosis in Chinese Han population. Arch Med Res 2010, 41:46-49.